The expression of NMDA receptor 1 is associated with clinicopathological parameters and prognosis in the oral squamos cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 33, Issue 9, 2004, Pages 533-537

  Choi, S W ^a   Park, S Y ^b   Hong, S P ^c   Pai, H ^d   Choi, J Y ^e   Kim, S G ^d,f  

^a National Cancer Institute   (South Korea)

^b National Cancer Center   (South Korea)

^c Seoul National University   (South Korea)

^d Hallym University   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

^f NONE   (South Korea)

Author keywords

Cancer stage; Glutamate receptor; N methyl D aspartate receptor 1; Overall survival

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL DIVISION; CELL MOVEMENT; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, N-METHYL-D-ASPARTATE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 4844227876     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00226.x     Document Type: Article

References (21)

1. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-97.
2. Hedstrom J, Grenman R, Ramsay H, et al. Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous cell carcinoma of the oral cavity and oropharynx. Int J Cancer 1999; 84: 525-8.
3. Kantola S, Parikka M, Jokinen K, et al. Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors. Br J Cancer 2000; 83: 614-9.
4. Quon H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 2001; 23: 147-59.
5. Watkins JC, Evans RH. Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 1981; 21: 165-204.
6. Cavalheiro EA, Lehmann J, Turski L. Frontiers in excitatory amino acid research. New York: Alan R. Liss, 1988.
7. Turski L, Cavalheiro EA, Schoepp DD. Excitatory amino acids: ten years later. Amsterdam: IOS Press, 2001.
8. Skerry TM, Genever PG. Glutamate signaling in non-neuronal tissues. Trends Pharmacol Sci 2001; 22: 174-81.
9. Rzeski W, Turski L, Ikonomidou C. Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 2001; 98: 6372-7.
10. International Union Against Cancer. TNM classification of malignant tumors. 5th edn. NY: Wiley-Liss, 1997; 1-50.
11. World Health Organization. International histological classification of tumours, 2nd edn. Berlin: Springer-Verlag, 1988.
12. Kishimoto K, Sasaki A, Yoshihama Y, Mese H, Tsukamoto G, Matsumura T. Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma. Oral Oncol 2003; 39: 391-6.
13. Foldes RL, Rampersad V, Kamboj RK. Cloning and sequence analysis of cDNAs encoding human hippocampus N-methyl-D-aspartate receptor subunits: evidence for alternative RNA splicing. Gene 1993; 131: 293-8.
14. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 1991; 354: 31-7.
15. Chenu C, Serre CM, Raynal C, Burt-Pichat B, Delmas PD. Glutamate receptor are expressed by bone cells and are involved in bone resorption. Bone 1998; 22: 295-9.
16. Komuro H, Rakic P. Modulation of neuronal migration by NMDA receptors. Science 1993; 260: 95-7.
17. Ikonomidou C, Bosch F, Miksa M, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999; 283: 70-4.
18. Schliephake H. Prognostic relevance of molecular markers of oral cancer - a review. Int J Oral Maxillofac Surg 2003; 32: 233-45.
19. Vora HH, Shah NG, Patel DD, Trivedi TI, Chikhlikar PR. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. J Surg Oncol 2003; 82: 34-50.
20. Gomez D, Faucher A, Picot V, et al. Outcome of squamous cell carcinoma of the gingiva: a follow-up study of 83 cases. J Craniomaxillofac Surg 2000; 28: 331-5.
21. Howaldt HP, Kainz M, Euler B, Vorast H. Proposal for modification of the TNM staging classification for cancer of the oral cavity. J Craniomaxillofac Surg 1999; 27: 275-88.